Purple Biotech Ltd.
PPBT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001614744
No open-market purchases or sales by Purple Biotech Ltd. insiders were filed in the last 90 days; 13 institutions reported holding it in 13F filings for Q2 2026, worth $141.0K in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Purple Biotech Ltd. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 9
- −4 vs. Q4 2024
- Shares held
- 50.7K
- −29.8K (−37.0%) vs. Q4 2024
- Total value
- $134.3K
- −$243.5K (−64.5%) vs. Q4 2024
- New holders
- 1
- 2 more added
- Sold out
- 5
- 3 more reduced
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PPBT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 13 | $141.0K |
| Q1 2026 | 15 | $305.6K |
| Q4 2025 | 19 | $513.2K |
| Q3 2025 | 16 | $75.9K |
| Q2 2025 | 14 | $133.7K |
| Q1 2025 | 9 | $134.3K |
| Q4 2024 | 14 | $377.9K |
| Q3 2024 | 11 | $946.1K |
| Q2 2024 | 21 | $775.9K |
| Q1 2024 | 21 | $1.77M |
| Q4 2023 | 20 | $1.90M |
| Q3 2023 | 18 | $275.9K |
| Q2 2023 | 17 | $388.3K |
| Q1 2023 | 16 | $224.2K |
| Q4 2022 | 15 | $238.6K |
| Q3 2022 | 11 | $224.0K |
| Q2 2022 | 14 | $310.2K |
| Q1 2022 | 14 | $1.77M |
| Q4 2021 | 13 | $4.09M |
| Q3 2021 | 12 | $5.27M |
| Q2 2021 | 13 | $3.72M |
| Q1 2021 | 15 | $2.40M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Purple Biotech Ltd.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| UBS Group AG | 23,025 | $61.2K | 0.00% | +12,242+113.5% | Added |
| Kingswood Wealth Advisors, LLC | 16,797 | $44.3K | 0.00% | −16,797−50.0% | Reduced |
| BNP Paribas Arbitrage, SA | 5,375 | $14.3K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 4,466 | $11.9K | 0.00% | −649−12.7% | Reduced |
| Rhumbline Advisers | 805 | $2.19K | 0.00% | +200+33.1% | Added |
| Northwestern Mutual Wealth Management Co | 85 | $226 | 0.00% | +85 | New |
| SBI Securities Co., Ltd. | 20 | $53 | 0.00% | −170−89.5% | Reduced |
| North Star Investment Management Corp. | 15 | $40 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 107 | $0 | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −15,374−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −8,568−100.0% | Sold out |
| Crowley Wealth Management, Inc. | 0 | $0 | 0.00% | −300−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −226−100.0% | Sold out |
| TD Waterhouse Canada Inc. | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Global Retirement Partners, LLC | – | – | – | – | Not filed |